BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 32575504)

  • 1. The Dysfunctional Immune System in Common Variable Immunodeficiency Increases the Susceptibility to Gastric Cancer.
    Gullo I; Costa C; Silva SL; Ferreira C; Motta A; Silva SP; Ferreira RD; Rosmaninho P; Faria E; Costa JTD; Câmara R; Gonçalves G; Santos-Antunes J; Oliveira C; Machado JC; Carneiro F; Sousa AE
    Cells; 2020 Jun; 9(6):. PubMed ID: 32575504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of
    Motta-Raymundo A; Rosmaninho P; Santos DF; Ferreira RD; Silva SP; Ferreira C; Sousa AE; Silva SL
    Front Immunol; 2022; 13():834137. PubMed ID: 35711410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastric Cancer Is the Leading Cause of Death in Italian Adult Patients With Common Variable Immunodeficiency.
    Pulvirenti F; Pecoraro A; Cinetto F; Milito C; Valente M; Santangeli E; Crescenzi L; Rizzo F; Tabolli S; Spadaro G; Agostini C; Quinti I
    Front Immunol; 2018; 9():2546. PubMed ID: 30455695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastric Cancer Screening in Common Variable Immunodeficiency.
    van der Poorten DK; McLeod D; Ahlenstiel G; Read S; Kwok A; Santhakumar C; Bassan M; Culican S; Campbell D; Wong SWJ; Evans L; Jideh B; Kane A; Katelaris CH; Keat K; Ko Y; Lee JA; Limaye S; Lin MW; Murad A; Rafferty M; Suan D; Swaminathan S; Riminton SD; Toong C; Berglund LJ
    J Clin Immunol; 2018 Oct; 38(7):768-777. PubMed ID: 30219982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastric pathology in patients with common variable immunodeficiency.
    Zullo A; Romiti A; Rinaldi V; Vecchione A; Tomao S; Aiuti F; Frati L; Luzi G
    Gut; 1999 Jul; 45(1):77-81. PubMed ID: 10369708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New insights into the inflamed tumor immune microenvironment of gastric cancer with lymphoid stroma: from morphology and digital analysis to gene expression.
    Gullo I; Oliveira P; Athelogou M; Gonçalves G; Pinto ML; Carvalho J; Valente A; Pinheiro H; Andrade S; Almeida GM; Huss R; Das K; Tan P; Machado JC; Oliveira C; Carneiro F
    Gastric Cancer; 2019 Jan; 22(1):77-90. PubMed ID: 29779068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastric adenocarcinoma in common variable immunodeficiency: features of cancer and associated gastritis may be characteristic of the condition.
    De Petris G; Dhungel BM; Chen L; Chang YH
    Int J Surg Pathol; 2014 Oct; 22(7):600-6. PubMed ID: 24788529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutrophil and Granulocytic Myeloid-Derived Suppressor Cell-Mediated T Cell Suppression Significantly Contributes to Immune Dysregulation in Common Variable Immunodeficiency Disorders.
    Vlkova M; Chovancova Z; Nechvatalova J; Connelly AN; Davis MD; Slanina P; Travnickova L; Litzman M; Grymova T; Soucek P; Freiberger T; Litzman J; Hel Z
    J Immunol; 2019 Jan; 202(1):93-104. PubMed ID: 30487174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic perspectives of PD-L1 combined with tumor-infiltrating lymphocytes, Epstein-Barr virus, and microsatellite instability in gastric carcinomas.
    Choi E; Chang MS; Byeon SJ; Jin H; Jung KC; Kim H; Lee KL; Kim W; Park JH; Kim KH; Kim JS; Choi IS; Han DS; Ahn HS; Heo SC
    Diagn Pathol; 2020 Jun; 15(1):69. PubMed ID: 32498695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastrointestinal tract pathology in patients with common variable immunodeficiency (CVID): a clinicopathologic study and review.
    Daniels JA; Lederman HM; Maitra A; Montgomery EA
    Am J Surg Pathol; 2007 Dec; 31(12):1800-12. PubMed ID: 18043034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastroduodenal Disorders in Patients with CVID Undergoing Immunoglobulin Therapy.
    Varricchi G; Pecoraro A; Crescenzi L; Marone G; Travaglino A; D'Armiento FP; Genovese A; Spadaro G
    Curr Pharm Biotechnol; 2018; 19(9):734-741. PubMed ID: 30336770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decline of gastric cancer mortality in common variable immunodeficiency in the years 2018-2022.
    Milito C; Pulvirenti F; Garzi G; Sculco E; Cinetto F; Firinu D; Lagnese G; Punziano A; Discardi C; Costanzo G; Felice C; Spadaro G; Ferrari S; Quinti I
    Front Immunol; 2023; 14():1231242. PubMed ID: 37868983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatic mutational profiles of stage II and III gastric cancer according to tumor microenvironment immune type.
    Koh J; Nam SK; Roh H; Kim J; Lee BC; Kim JW; Ahn SH; Park DJ; Kim HH; Park KU; Chung JH; Kim WH; Lee HS
    Genes Chromosomes Cancer; 2019 Jan; 58(1):12-22. PubMed ID: 30239046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathologic implications of immune classification by PD-L1 expression and CD8-positive tumor-infiltrating lymphocytes in stage II and III gastric cancer patients.
    Koh J; Ock CY; Kim JW; Nam SK; Kwak Y; Yun S; Ahn SH; Park DJ; Kim HH; Kim WH; Lee HS
    Oncotarget; 2017 Apr; 8(16):26356-26367. PubMed ID: 28412752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poor prognosis in Epstein-Barr virus-negative gastric cancer with lymphoid stroma is associated with immune phenotype.
    Cho CJ; Kang HJ; Ryu YM; Park YS; Jeong HJ; Park YM; Lim H; Lee JH; Song HJ; Jung HY; Kim SY; Myung SJ
    Gastric Cancer; 2018 Nov; 21(6):925-935. PubMed ID: 29627937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CVID-Associated Tumors: Czech Nationwide Study Focused on Epidemiology, Immunology, and Genetic Background in a Cohort of Patients With CVID.
    Kralickova P; Milota T; Litzman J; Malkusova I; Jilek D; Petanova J; Vydlakova J; Zimulova A; Fronkova E; Svaton M; Kanderova V; Bloomfield M; Parackova Z; Klocperk A; Haviger J; Kalina T; Sediva A
    Front Immunol; 2018; 9():3135. PubMed ID: 30723478
    [No Abstract]   [Full Text] [Related]  

  • 17. Increased intratumoral mast cells foster immune suppression and gastric cancer progression through TNF-α-PD-L1 pathway.
    Lv Y; Zhao Y; Wang X; Chen N; Mao F; Teng Y; Wang T; Peng L; Zhang J; Cheng P; Liu Y; Kong H; Chen W; Hao C; Han B; Ma Q; Zou Q; Chen J; Zhuang Y
    J Immunother Cancer; 2019 Feb; 7(1):54. PubMed ID: 30808413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired CD8(+) T cell responses upon Toll-like receptor activation in common variable immunodeficiency.
    de Lollo C; de Moraes Vasconcelos D; da Silva Oliveira LM; de Oliveira Titz T; Carneiro-Sampaio M; Jacob CM; da Silva Duarte AJ; Sato MN
    J Transl Med; 2016 May; 14(1):138. PubMed ID: 27188997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotypic Analysis of CD4+ Treg, CD8+ Treg, and Breg Cells in Adult Common Variable Immunodeficiency Patients.
    Yesillik S; Agrawal S; Gollapudi SV; Gupta S
    Int Arch Allergy Immunol; 2019; 180(2):150-158. PubMed ID: 31284281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IVIg immune reconstitution treatment alleviates the state of persistent immune activation and suppressed CD4 T cell counts in CVID.
    Paquin-Proulx D; Santos BA; Carvalho KI; Toledo-Barros M; Barreto de Oliveira AK; Kokron CM; Kalil J; Moll M; Kallas EG; Sandberg JK
    PLoS One; 2013; 8(10):e75199. PubMed ID: 24130688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.